MONOAMINE OXIDASE DEFICIENCY FOUND… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Principal Officer

BARBARA SASSER

Phone

4095996143

Tax Period

2025-01-01 to 2025-12-31

MONOAMINE OXIDASE DEFICIENCY FOUNDATION, founded in 2022, is a small nonprofit in the Medical Research sector that reported $845K in total revenue in fiscal year 2025. Revenue decreased 8% compared to the prior year.

Mission

THE PRIMARY CHARITABLE MISSION OF THE MONOAMINE OXIDASE DEFICIENCY FOUNDATION (THE "CORPORATION") IS TO INCREASE AWARENESS OF AND PROVIDE FUNDING FOR RESEARCH RELATED TO MONOAMINE OXIDASE ("MAO") DEFICIENCY SYNDROMES, AND TO DO SO WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (OR THE CORRESPONDING PROVISION OF ANY FUTURE UNITED STATES INTERNAL REVENUE LAW).

Program Service Accomplishments

Program 1

Expenses: $834,698 Revenue: $845,166

TO INCREASE AWARENESS OF AND PROVIDE FUNDING FOR RESEARCH RELATED TO MONOAMINE OXIDASE ("MAO") DEFICIENCY SYNDROMES

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $840,413

Program Service Revenue $0

Investment Income $4,753

Other Revenue $0

TOTAL REVENUE $845,166

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $834,698

Other Expenses $840,523

TOTAL EXPENSES $840,523

Year-over-Year Comparison

	2025	2024	Change
Revenue	$845,166	$920,729	-0.1%
Expenses	$840,523	$740,669	+0.1%
Net Income	$4,643	$180,060	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BARBARA SASSER	PRESIDENT	0.50	Director	$0	$0	$0
ZACHARY SASSER	VICE-PRESIDENT	0.50	Director	$0	$0	$0
KATHERINE GRAHAM	SECRETARY	0.50	Director	$0	$0	$0
PAMELA VIGIL	AT LARGE	0.50	Director	$0	$0	$0
CYNTHIA TAYS	AT LARGE	0.50	Director	$0	$0	$0
SALLY PROVOW	AT LARGE	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$845,166	$840,523	$209,550	$4,643
2024	$920,729	$740,669	$204,907	$180,060
2023	$414,965	$416,221	$22,175	$-1,256
2022	$403,656	$380,225	$23,431	$23,431

MONOAMINE OXIDASE DEFICIENCY FOUNDATION